A PYMNTS Company

Bausch + Lomb gets early termination of HSR waiting period for ISTA acquisition

By  |  April 24, 2012

Bausch + Lomb has received early termination of the Hart-Scott-Rodino waiting period for its pending acquisition of ISTA Pharmaceuticals. California-based ISTA is the third-largest branded prescription eye care business in the United States. Bausch + Lomb is headquarted in New York; its core businesses center around contact lenses and other ophthalmic products.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full content: MarketWatch

     

    Related content: The AZ Judgment: A Green Light for Further Action on Pharma and IP (Sean-Paul Brankin, Crowell & Moring)

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.